We are live on ! Find out more
RVMD icon

Revolution Medicines
RVMD

119 hedge funds and large institutions have $2.27B invested in Revolution Medicines in 2020 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 12

68% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 22

33% more funds holding in top 10

Funds holding in top 10: 9 → 12 (+3)

32% more funds holding

Funds holding: 90 → 119 (+29)

15% more capital invested

Capital invested by funds: $1.98B → $2.27B (+$291M)

0.11% more ownership

Funds ownership: 86.4% → 86.51% (+0.11%)

Holders
119
Holders Change
+29
Holders Change %
+32.22%
% of All Funds
2.11%
Holding in Top 10
12
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+33.33%
% of All Funds
0.21%
New
42
Increased
37
Reduced
22
Closed
12
Calls
$23K
Puts
–
Net Calls
+$23K
Net Calls Change
+$23K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$38.6M
2
Citadel Advisors
Citadel Advisors
Florida
+$34.2M
3
WP
Woodline Partners
California
+$30.8M
4
State Street
State Street
Massachusetts
+$28.5M
5
BI
BVF Inc
California
+$26.4M

Top Sellers

Rank Fund Capital Flow
1
TGI
TRV GP III
Massachusetts
-$39.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$21.7M
3
DM
Deerfield Management
New York
-$15.8M
4
Franklin Resources
Franklin Resources
California
-$12.6M
5
SAM
Sectoral Asset Management
Quebec, Canada
-$9.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
51
RhumbLine Advisers
Massachusetts
$1.83M +$190K +4,799 +12%
Swiss National Bank
52
Swiss National Bank
Switzerland
$1.77M +$336K +8,500 +23%
BG
53
Bellevue Group
Switzerland
$1.58M +$1.58M +40,000 New
New York State Common Retirement Fund
54
New York State Common Retirement Fund
New York
$1.38M – – –
Deutsche Bank
55
Deutsche Bank
Germany
$1.33M +$501K +12,666 +60%
Ensign Peak Advisors
56
Ensign Peak Advisors
Utah
$1.28M +$287K +7,265 +29%
Morgan Stanley
57
Morgan Stanley
New York
$1.2M -$868K -21,957 -42%
B
58
Bailard
California
$1.16M +$1.16M +29,300 New
Arrowstreet Capital
59
Arrowstreet Capital
Massachusetts
$1.13M +$1.13M +28,500 New
Thrivent Financial for Lutherans
60
Thrivent Financial for Lutherans
Minnesota
$1.09M +$1.09M +27,482 New
UBS AM
61
UBS AM
Illinois
$983K +$701K +17,729 +250%
Principal Financial Group
62
Principal Financial Group
Iowa
$926K +$694K +17,565 +302%
DCM
63
DAFNA Capital Management
California
$891K +$890K +22,500 New
Manulife (Manufacturers Life Insurance)
64
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$889K +$67.6K +1,710 +8%
Federated Hermes
65
Federated Hermes
Pennsylvania
$868K +$867K +21,933 New
DekaBank Deutsche Girozentrale
66
DekaBank Deutsche Girozentrale
Germany
$842K +$830K +21,000 New
AC
67
Athanor Capital
New York
$794K +$232K +5,855 +41%
ProShare Advisors
68
ProShare Advisors
Maryland
$744K +$743K +18,790 New
EAM
69
Erste Asset Management
Austria
$703K +$688K +17,400 New
Invesco
70
Invesco
Georgia
$679K +$678K +17,153 New
VOYA Investment Management
71
VOYA Investment Management
Georgia
$665K +$159K +4,018 +31%
VC
72
Vivo Capital
California
$661K -$3.27M -82,827 -83%
MIM
73
MetLife Investment Management
New Jersey
$659K – – –
Rafferty Asset Management
74
Rafferty Asset Management
New York
$635K -$96.3K -2,435 -13%
Susquehanna International Group
75
Susquehanna International Group
Pennsylvania
$586K +$252K +6,361 +75%
1 2
3
4 5

RVMD Hedge Fund Activity: Q4 2020 in Review

119 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Revolution Medicines (RVMD) for Q4 2020, worth a combined $2.27B — up 15% from $1.98B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new RVMD positions and 12 closed out — a net gain of 30 holders — while 37 added to existing stakes and 22 trimmed.

The largest buyer was BlackRock, adding an estimated $38.6M. The largest seller was TRV GP III, cutting an estimated $39.5M.

  • 119 institutional investors held Revolution Medicines (RVMD) as of Q4 2020, up from 90 in Q3 2020.
  • Funds reported $2.27B of Revolution Medicines stock for Q4 2020, up 15% quarter-over-quarter.
  • 42 funds opened new Revolution Medicines positions in Q4 2020 and 12 closed out, a net change of +30 holders.
  • The largest Revolution Medicines buyer in Q4 2020 was BlackRock, an estimated $38.6M added.
  • The largest Revolution Medicines seller in Q4 2020 was TRV GP III, an estimated $39.5M sold.

Based on aggregated 13F filings for Q4 2020.